Market Access

• Preparation of Pricing or Exceptional Price Review applications
• Preparation of Added Therapeutic Value Dossier, fulfilling all the
requirements of DL 97/2015, June 1st
• Both for prior assessment or reimbursement procedures
•Follow up during the evaluation process including including replies to
evaluators
• Personal attendance to meetings with INFARMED
• Opinion and advice on strategic decisions